CX-011

N/A

Report date: 2026/02/05 20:00:17
NMEFirst In Class

Base Information

Drug NameCX-011
Drug Alias NameCX-011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-6 receptor subunit beta modulators
TargetsInterleukin-6 receptor subunit beta
Therapy Area/IndicationsOsteoarthritis, KneeOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCarthroniX Inc
China Registration ClassN/A

Develop Information

Active CompaniesCarthroniX Inc
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, KneeOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A